Janssen Search
Search results
R&D Focus Areas
Our Areas of Focus We leverage our world-class discovery and development expertise, as well as our operational excellence, to bring innovative, effective treatments in six therapeutic areas and advanced biotherapeutic and research platforms: ...
A Collaborative Model
Article Type: Human Microbiome Institute A Collaborative Model We believe that fostering cooperation and partnerships within the scientific and medical communities is essential to effectively translate promising microbiome science into solutions that ...
BIO-Europe Spring 2018
BIO-Europe Spring 2018 will take place March 12- 14, 2018, in Amsterdam. The conference brings together hundreds of the world’s most innovative leaders across biotech, finance and pharma for high-level networking, pre-scheduled partnering meetings, ...
Our Recognition
Article Block Text: We are honored to receive awards and recognition for our work and community contributions around the world. Article Type: Explore We are honored to receive awards and recognition for our work and community contributions around the ...
Pamela Carroll, Ph.D.
Pamela Carroll, Ph.D. is Vice President of Oncology Scientific Innovation at Janssen Research & Development, LLC. She represents the Oncology Therapeutic Area in Johnson & Johnson Innovation, Boston and is responsible for leading partnerships and ...
Pamela Carroll, Ph.D.
Pamela Carroll, Ph.D. is Vice President of Oncology Scientific Innovation at Janssen Research & Development, LLC. She represents the Oncology Therapeutic Area in Johnson & Johnson Innovation, Boston and is responsible for leading partnerships and ...
Immunology
Immunology Immunology Air-liquid interface culture of colonic epithelial cells; Clara Moon, Janssen R&D Skin cells at 20x magnification About Our Immunology Innovations Discoveries in Immunology Disease Treatment Development Capabilities ...
Infectious Diseases & Vaccines
Infectious Diseases & Vaccines Infectious Diseases & Vaccines The structure of HIV Creating Treatments for Infectious Diseases Discovery & Development Global Reach Respiratory Infections Chronic Infections Bacterial Infections Other Focus ...
About Our Global Public Health Initiative
Janssen’s Commitment to Global Public Health At Janssen, the Pharmaceutical Companies of Johnson & Johnson, we have a single overarching mission: to address and solve the most important unmet medical needs of our time. Janssen aims to build on our ...
Ann Beliën, Ph.D.
Ann Beliën contributes to development of the Janssen Prevention Center’s discovery portfolio in two main ways. In her Management Team role as Head of Strategy, she is responsible for providing the Global Head of the Janssen Prevention Center with a clear ...